Recently Approved Alzheimer Drug Raises Questions That Might Never Be Answered

MeSH terms

• Alzheimer Disease / drug therapy*
• Alzheimer Disease / etiology
• Amyloid beta-Peptides / drug effects
• Antibodies, Monoclonal, Humanized / therapeutic use*
• Biomarkers
• Clinical Trials as Topic
• Conflict of Interest
• Drug Approval* / legislation & jurisprudence
• Drug Industry / ethics
• Drug Labeling
• Humans
• Plaque, Amyloid / complications
• Plaque, Amyloid / drug therapy*
• United States
• United States Food and Drug Administration* / ethics
• United States Food and Drug Administration* / legislation & jurisprudence